Asthma Therapeutics Market 2018-2025 Current Trends Analysis and Forecast For Research Industry - AstraZeneca Plc, Philips Healthcare, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline Plc, Sanofi-Aventis SA, CareFusion Corporation, Sunovion Pharmaceut

Asthma therapeutics market is estimated to represent a global market of USD 20.1 billion by 2017 with growth rate of 1.9%. Key drivers of the market include rising prevalence of asthma and other respiratory disorders. As per the World Health Organization (WHO), more than 235 million people suffer from asthma globally. Around 3,38,000 deaths were reported in 2015 and most deaths occur among older adults. Further, introduction of technologically advanced products and rising awareness levels about these disorders is anticipated to drive the market growth. Rising research in the field of biologics for asthma treatment is seen as most promising opportunity. Biologics targeting pro-inflammatory cytokines and other inflammatory mediators may be of therapeutic benefit. However, expiry of leading branded drugs such as Singulair (montelukast sodium), Symbicort (budesonide/formoterol fumarate), Advair (fluticasone propionate/salmeterol xinafoate), and Xolair (omalizumab) is anticipated to hamper the market growth

Get sample copy of this report: http://www.reportsweb.com/inquiry&RW00011327816/sample

This report studies the global Asthma therapeutics market, analyzes and researches the Asthma therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. The report analyses the entire production and supply chain of the Market and provides information as per different phases. Whereas, on the basis of sales, data related to sales volume, sales price, cost, sales income, and profit margin etc. of Strategy Consulting Market used in different fields, sold in different regions and by different companies is provided in this report.

Top Manufacturers :AstraZeneca Plc, Philips Healthcare, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline Plc, Sanofi-Aventis SA, CareFusion Corporation, Sunovion Pharmaceuticals, Inc., Boehringer Ingelheim GmbH, Roche Diagnostics, and Merck & Co., Inc

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type

Drug Class
Products 
Route
Market Segment by Applications, can be divided into

MARKET, BY DRUG CLASSS

Anti-inflammatory

Bronchodilators

Combination Therapy

MARKET, BY PRODUCTS

Inhalers

Nebulizers

MARKET, BY ROUTE

Oral

Inhaled

Subcutaneous

Intravenous

The global Asthma therapeutics market is segmented on the basis of drug class, product, route of administration and region. On the basis of drug class, the market is segmented into anti- inflammatory, bronchodilators and combination therapy. Combination therapy dominated the market share owing to its high adoption rates and utilization. Anti- inflammatory drugs are expected to witness market growth owing to R&D developments pertaining to biologics. Patent expiration of anti- inflammatory drugs during the forecast period will have impact on the revenue generation. Anti- inflammatory segment is expected to witness the fastest market growth.

On the basis of route of administration, the market is segmented into oral, inhaled and other routes. Inhaled route of administration accounted for the largest revenue in the year 2015. This is due to effective pharmacodynamics and pharmacokinetic actions upon administration of drug dose by this route. Oral route of administration is expected to emerge as the fastest growing market over the forecast period.

Complete Report: http://www.reportsweb.com/asthma-therapeutics-market-analysis-and-forecast-report-2018-2025

About ReportsWeb:
ReportsWeb is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers.

Contact Us:
Phone: +1-646-491-9876
Email Id: sales@reportsweb.com

This release was published on openPR.